<?xml version="1.0" encoding="UTF-8"?>
<p>EBOVAC-Salone study approvals were required from the London School of Hygiene &amp; Tropical Medicine Ethics Committee, the Sierra Leone Ethical and Scientific Review Committee, and the Pharmacy Board of Sierra Leone the national regulatory authority. During the Ebola epidemic, the African Vaccine Regulatory Forum, with support from the World Health Organization, established a platform for conducting joint reviews of clinical trial applications with input from international regulatory agencies. This aimed to achieve rapid comprehensive reviews of clinical trials in the context of potentially limited regulatory and ethics review capacity in the sub-Saharan African countries participating in Ebola vaccine trials.
 <sup>
  <xref rid="bibr12-1740774518780678" ref-type="bibr">12</xref>
 </sup> The EBOVAC-Salone study team engaged with the African Vaccine Regulatory Forum review process at a meeting in April 2015 that was also attended by the Pharmacy Board of Sierra Leone and the Sierra Leonean ethics committee.
</p>
